Business Description
Mydecine Innovations Group Inc
NAICS : 325411
SIC : 3741
ISIN : CA64157D1087
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -1.46 | |||||
Debt-to-Equity | -0.84 | |||||
Debt-to-EBITDA | -0.22 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 66 | |||||
3-Year EPS without NRI Growth Rate | 43.8 | |||||
3-Year FCF Growth Rate | 34.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.58 | |||||
9-Day RSI | 55.91 | |||||
14-Day RSI | 54.25 | |||||
6-1 Month Momentum % | -86.67 | |||||
12-1 Month Momentum % | -94.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.71 | |||||
Quick Ratio | 0.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -181.4 | |||||
Shareholder Yield % | -546.24 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -591.31 | |||||
ROIC % | -2990.05 | |||||
ROC (Joel Greenblatt) % | -14061.89 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.25 | |||||
EV-to-EBITDA | -0.25 | |||||
EV-to-Forward-Revenue | 0.74 | |||||
EV-to-FCF | -1.02 | |||||
Earnings Yield (Greenblatt) % | -400 | |||||
FCF Yield % | -610.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mydecine Innovations Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -2.08 | ||
Beta | 1.17 | ||
Volatility % | 130.08 | ||
14-Day RSI | 54.25 | ||
14-Day ATR (C$) | 0.00262 | ||
20-Day SMA (C$) | 0.01775 | ||
12-1 Month Momentum % | -94.67 | ||
52-Week Range (C$) | 0.01 - 0.4 | ||
Shares Outstanding (Mil) | 52.57 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mydecine Innovations Group Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mydecine Innovations Group Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Mydecine Innovations Group Inc Frequently Asked Questions
What is Mydecine Innovations Group Inc(XCNQ:MYCO)'s stock price today?
When is next earnings date of Mydecine Innovations Group Inc(XCNQ:MYCO)?
Does Mydecine Innovations Group Inc(XCNQ:MYCO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |